Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
SHORT INTEREST
168.36K 09/13/19
P/E Current
-2.69
P/E Ratio (with extraordinary items)
-5.04
Average Recommendation: BUY
Average Target Price: 7.50
SHORT INTEREST
168.36K 09/13/19
P/E Current
-2.69
P/E Ratio (with extraordinary items)
-5.04
Average Recommendation: BUY
Average Target Price: 7.50
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media